Clinical Trial Update: Treatment of Recurrent Bladder Cancer With Dendritic Cells [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dendritic cell therapy for recurrent bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Dendritic Cells Therapy

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED